VGI Health Technology Limited (NSX:VTL) is pleased to announce that the United States Patent and Trademarks Office (USPTO) intends to grant a divisional patent for the Transmucosal Delivery of Tocotrienols to its wholly-owned subsidiary Invictus Biotechnology Pty Ltd.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting an abstract at the American Society for Nutrition (ASN) Annual Conference, Nutrition 2022.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that Dr Jordan Moon, a member of its Scientific Advisory Board, will be presenting two abstracts at the American Physiological Society s (APS) Annual Meeting Experimental Biology Conference 2022 in Philadelphia, USA.
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has executed a non-binding Term Sheet for the sale of its wholly owned subsidiary, the Invictus BioPharma Pty Ltd Group to Invictus BioPharma Holdings Ltd.